A review and commentary on a sample of 15 UK guidelines for the drug treatment of Alzheimer's disease

International Journal of Geriatric Psychiatry

Volumn 14, Issue 4, 1999, Pages 249-256

  Harvey, Richard J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer's disease; Cholinesterase inhibitors; Diagnosis; Evidence based medicine; Guidelines; Treatment

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL;

ALZHEIMER DISEASE; ARTICLE; EVIDENCE BASED MEDICINE; HUMAN; MAINTENANCE THERAPY; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; TREATMENT PLANNING; UNITED KINGDOM;

AGED; ALZHEIMER DISEASE; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NOOTROPIC AGENTS; PRACTICE GUIDELINES;

EID: 0032925043     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1166(199904)14:4<249::AID-GPS920>3.0.CO;2-T     Document Type: Article

References (18)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV), APA, Washington, DC.
2. Bandolier (1997) New dementia drug. Bandolier 40, 2-5.
3. Barker, A., Cope, D., Lapthorne, C., Mears, H., Sheehan, B., Wilkinson, D. and Wessex Specialists in Old Age Psychiatry (1997) Guidelines for the use of anti-Alzheimer drugs: Consensus document by the Wessex Specialists in the Psychiatry of Old Age.
4. Corey Bloom, J., Anand, R., Veach, J. and ENA 713 B352 Study Group (1998) A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. Int. J. Geriatr. Psychopharmacol. 1, 55-65.
5. Denig, P. and Haaijer-Ruskamp, F. M. (1994) 'Thinking aloud' as a method of analysing the treatment decisions of physicians. Eur. J. Pub. Health 5, 55-59.
6. Drug and Therapeutics Bulletin (1997) Donepezil for Alzheimer's disease? Drug Therapeut. Bull. 35, 75-76.
7. Eccles, M., Clapp, Z., Grimshaw, J., Adams, P. C., Higgins, B., Purves, I. and Russell, I. (1996) North of England evidence based guidelines development project: Methods of guideline development. Brit. Med. J. 312, 760-762.
8. Jackson, R. and Feder, G. (1998) Guidelines for clinical guidelines. Brit. Med. J. 317, 427-438.
9. Jones, R., Compton, S., Goddard, C., Fairbairn, A., Gregg, L. and Working Group of the College's Section for the Psychiatry of Old Age (1997) Interim statement on anti-dementia drugs: Implications, concerns and policy proposals. Psychiatr. Bull. 21, 586-587.
10. Kelly, C. A., Harvey, R. J. and Cayton, H. (1997) Treatment for Alzheimer's disease raises clinical and ethical issues. Brit. Med. J. 314, 693-694.
11. Knapp, M. J., Knopman, D. S., Solomon, P. R., Pendlebury, W. W., Davis, C. S. and Gracon, S. I. (1994) A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease: The Tacrine Study Group. JAMA 271, 985-991.
12. Lovestone, S., Howard, R., Graham, N. and London Alzheimer's Disease Treatment Working Group (1997) Guidelines on drug treatments for Alzheimer's disease. Lancet 350, 232-233.
13. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurol. 34, 939-944.
14. Rogers, S. L., Farlow, M. R., Mohs, R., Friedhoff, L. T. and Donepezil Study Group (1998) A 24-week double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurol. 50, 136-145.
15. Rogers, S. L. and Friedhoff, L. T. (1996) The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia 7, 293-303.
16. Rogers, S. L. and Friedhoff, I. T. (1998) Long term efficacy and safety of donepezil in the treatment of Alzheimer's disease: An interim analysis of the results of a US multicentre open label extension study. Eur. Neuropsychopharmacol. 8, 67-75.
17. Wilcock, G. (1994) Tacrine for Alzheimer's disease: Why is it not available on prescription to UK sufferers? Age Ageing 23, 353-355.
18. World Health Organisation (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, 10th edn. World Health Organisation, Geneva.